. 2020 Nov 13;42(4):1197–1205. doi: 10.1002/hbm.25286

TABLE 2.

Clinical information at baseline and follow‐up. Numbers in parentheses represent the SD

	Baseline	Follow‐up
Antipsychotics (Med/Unmed)	69/13	60/22
Antipsychotics (CPZ equivalent dose, mg/day)	227.4 (154.4)	307.3 (305.9)
BPRS improved/did not improve ^a	—	47/35 (57.3% improved)
Total BPRS score	42.7 (9.7)	37.3 (9.0)

Abbreviations: BPRS, Brief Psychiatric Rating Scale; CPZ, chlorpromazine; HC, healthy controls.

^{^a}

Clinical “improvement” was defined as showing >20% decrease (with lowest possible score [24] set to zero) on total BPRS score at follow‐up (vs. baseline). Only patients with total BPRS score >=29 at baseline were included in the sample.